Breast Cancer with Low Recurrence Score on Oncotype DX©: Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation

被引：0
|
作者：
Yonaton Zarbiv
Yael Berner Wygoda
Albert Grinshpun
Tamar Hamburger
Tamar Sella
Shani Breuer
Ofra Maimon
Yakir Rottenberg
Tamar Peretz
Luna Kadouri
机构：
[1] Sharett Institute of Oncology,Faculty of Medicine
[2] Hadassah Medical Center,Department of Radiology
[3] The Hebrew University of Jerusalem,undefined
[4] Wohl Institute for Translational Medicine,undefined
[5] Hadassah Medical Center,undefined
[6] Hadassah Medical Center,undefined
来源：
Oncology and Therapy | 2022年 / 10卷
关键词：
Breast cancer; Recurrence; Recurrence score; BRCA1/2; Invasive lobular carcinoma; Prognostic genomic test; Predictive genomic test;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：441 / 450
页数：9
相关论文
共 50 条
  • [41] Comparison of Oncotype DX™ Recurrence Score by Histologic Subtype of Breast Carcinoma
    Bomeisl, P. E.
    Thompson, C. L.
    Harris, L. N.
    Gilmore, H. L.
    LABORATORY INVESTIGATION, 2013, 93 : 30A - 31A
  • [42] Comparison of Oncotype DX™ Recurrence Score by Histologic Subtype of Breast Carcinoma
    Bomeisl, P. E.
    Thompson, C. L.
    Harris, L. N.
    Gilmore, H. L.
    MODERN PATHOLOGY, 2013, 26 : 30A - 31A
  • [43] Comparison of Oncotype DX Recurrence Score by Histologic Types of Breast Carcinoma
    Sahin, A.
    BREAST DISEASES, 2016, 27 (02): : 129 - 130
  • [44] BRCA Mutation Association with Recurrence Score and Discordance in a Large Oncotype Database
    Blanter, Julia
    Zimmerman, Brittney
    Tharakan, Serena
    Ru, Meng
    Cascetta, Krystal
    Tiersten, Amy
    ONCOLOGY, 2020, 98 (04) : 248 - 251
  • [45] Evaluation Oncotype DX® 21-Gene Recurrence Score and clinicopathological parameters in early stage breast cancer
    Lashen, A. L.
    Toss, M. T.
    Fadhil, W. F.
    Oni, G. O.
    Madhusudan, S. M.
    Rakha, E. R.
    JOURNAL OF PATHOLOGY, 2023, 261 : S10 - S10
  • [46] Does Mode of Surgical Intervention Based on Oncotype DX Score Influence Disease Recurrence in Early Breast Cancer?
    Aherne, T. M.
    Boland, M. R.
    Catargiu, D.
    Bashar, K.
    McVeigh, T. P.
    Brodie, C.
    Sweeney, K. J.
    SURGERY JOURNAL, 2020, 6 (02): : e135 - e138
  • [47] Is there a role for the oncotype DX breast recurrence score genomic assay in estrogen receptor-low positive breast cancer?
    Giordano, Julia
    McGrath, Monica
    Harrison, Beth
    Kantor, Olga
    Vora, Halley
    Burstein, Harold J.
    Tolaney, Sara M.
    King, Tari A.
    Mittendorf, Elizabeth A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [48] CORRELATING KI67 AND OTHER PROGNOSTIC MARKERS WITH ONCOTYPE DX RECURRENCE SCORE IN EARLY BREAST CANCER
    Li, Bob T.
    Danieletto, Suzanne
    Fong, Eva S.
    Li, Angela E.
    Currer, Trevor
    Parasyn, Andrew
    Middleton, Philip
    Wong, Heidi
    Smart, Denis
    Hughes, Michael
    Rutovitz, Josie J.
    Marx, Gavin M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 300 - 301
  • [49] CORRELATING KI67 AND OTHER PROGNOSTIC MARKERS WITH ONCOTYPE DX RECURRENCE SCORE IN EARLY BREAST CANCER
    Nahar, K.
    Li, B. T.
    Hughes, M.
    Danieletto, S.
    Fong, E. S.
    Li, A. E.
    Currer, T.
    Parasyn, A.
    Middleton, P.
    Wong, H.
    Smart, D.
    Clarke, S.
    Pavlakis, N.
    Rutovitz, J. J.
    Marx, G. M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 42 - 42
  • [50] Impact of Oncotype DX recurrence score in the management of pN1mic early breast cancer.
    Novas, Patricia
    Calvo, Elena Galve
    Gonzalez, Maria Angeles Sala
    Arteaga, Juan Fernando Arango
    Vicente, Borja Lopez De San
    Arrazubi, Virginia
    Zumarraga, Ane
    Santillan, Maria Lopez
    Martinez, Purification
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345